Similar articles

• Adrenergic responses in the human eye.

  Langham ME, Kitazawa Y, Hart RW. Langham ME, et al. J Pharmacol Exp Ther. 1971 Oct;179(1):47-55. J Pharmacol Exp Ther. 1971. PMID: 4938137 Clinical Trial. No abstract available.
• The influence of structurally related sympathomimetic amines on ocular dynamics.

  Lorenzetti OJ. Lorenzetti OJ. Ann Ophthalmol. 1971 Mar;3(3):282-8. Ann Ophthalmol. 1971. PMID: 5163957 No abstract available.
• Adrenergic drugs: ocular vasomotricity and vascular permeability.

  Virno M, Pellegrino N, Pecori-Giraldi J, Cozza R. Virno M, et al. Bibl Anat. 1979;(18):284-9. Bibl Anat. 1979. PMID: 496849 No abstract available.
• Fluorophotometric studies of prostaglandin effects on the human eye: the lack of association of reduced intraocular pressure with altered flow or barrier function.

  Brubaker RF. Brubaker RF. Prog Clin Biol Res. 1989;312:477-81. Prog Clin Biol Res. 1989. PMID: 2678151 Review. No abstract available.
• Prostaglandins and other eicosanoids: their ocular transport, pharmacokinetics, and therapeutic effects.

  Bito LZ. Bito LZ. Trans Ophthalmol Soc U K (1962). 1986;105 ( Pt 2):162-70. Trans Ophthalmol Soc U K (1962). 1986. PMID: 3541303 Review.